JamesJE. Caffeine and Health. London: Academic Press, 1991.
2.
EskelinenMH, KivipeltoM. Caffeine as a protective factor in dementia and Alzheimer's disease. J Alzheimer's Dis, 2010; 20:S167–S174.
3.
CostaJ, LunetN, SantosC, SantosJ, Vaz-CarneiroA. Caffeine exposure and the risk of Parkinson's disease: A systematic review and meta-analysis of observational studies. J Alzheimer's Dis, 2010; 20:S221–S238.
4.
CorleyJ, JiaX, KyleJAM, GowAJ, BrettCE, StarrJM, McNeillG, DearyIJ. Caffeine consumption and cognitive function at age 70: The Lothian Birth Cohort 1936 Study. Psychosom Med, 2010; 72:206–214.
5.
JamesJE. Caffeine and blood pressure: Habitual use is a preventable cardiovascular risk factor. Lancet, 1997; 349:279–281.
6.
JamesJE. A critical review of dietary caffeine and blood pressure: A relationship that should be taken more seriously. Psychosom Med, 2004; 66:63–71.
7.
JulianoLM, GriffithsRR. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology, 2004; 176:1–29.
8.
JamesJE, RogersPJ. Effects of caffeine on performance and mood: Withdrawal reversal is the most plausible explanation. Psychopharmacology, 2005; 182:1–8.
9.
BonnetMH, BalkinTJ, DingesDF, RoehrsT, RogersNL, WesenstenNJ. The use of stimulants to modify performance during sleep loss: A review by the sleep deprivation and stimulant task force of the American Academy of Sleep Medicine. Sleep, 2005; 28:1163–1187.
10.
JamesJE, KeaneMA. Caffeine, sleep and wakefulness: Implications of new understanding about withdrawal reversal. Hum Psychopharmacol Clin Exp, 2007; 22:549–558.
